— Publications

First Quarter 2019 Results 

All financial reports

— Media releases

June 20, 2019

Valneva Announces Mutual Agreement with GSK to End Strategic Alliance Agreement; Regains Control of R&D

Read more

— Upcoming events

Annual General Meeting
June 27, 2019, Paris
Read more

Valneva R&D Investor Day
July 9, 2019, New York City
Read more

All dates

— Lyme Disease

Download brochure


— Our responsibility

Committed to people, protecting lives and the environment

Learn more

play video
“We have the only
clinical-stage vaccine program
against Lyme disease 

Valneva's CEO Thomas Lingelbach
comments on Group Strategy

Subscribe to our Newsletter


Contact Investor Relations


Please update your browser...